133 related articles for article (PubMed ID: 12493028)
1. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays.
Gulmann C; Butler D; Kay E; Grace A; Leader M
Histopathology; 2003 Jan; 42(1):70-6. PubMed ID: 12493028
[TBL] [Abstract][Full Text] [Related]
2. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.
Hoos A; Urist MJ; Stojadinovic A; Mastorides S; Dudas ME; Leung DH; Kuo D; Brennan MF; Lewis JJ; Cordon-Cardo C
Am J Pathol; 2001 Apr; 158(4):1245-51. PubMed ID: 11290542
[TBL] [Abstract][Full Text] [Related]
3. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx.
Griffin MC; Robinson RA; Trask DK
Mod Pathol; 2003 Dec; 16(12):1181-8. PubMed ID: 14681317
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.
Gomaa W; Ke Y; Fujii H; Helliwell T
Virchows Arch; 2005 Oct; 447(4):701-9. PubMed ID: 16012850
[TBL] [Abstract][Full Text] [Related]
5. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
Boku N; Chin K; Hosokawa K; Ohtsu A; Tajiri H; Yoshida S; Yamao T; Kondo H; Shirao K; Shimada Y; Saito D; Hasebe T; Mukai K; Seki S; Saito H; Johnston PG
Clin Cancer Res; 1998 Jun; 4(6):1469-74. PubMed ID: 9626464
[TBL] [Abstract][Full Text] [Related]
6. Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma.
Saito H; Tujitani S; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999; 57(2):164-72. PubMed ID: 10461065
[TBL] [Abstract][Full Text] [Related]
7. Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.
Berlth F; Mönig SP; Schlösser HA; Maus M; Baltin CT; Urbanski A; Drebber U; Bollschweiler E; Hölscher AH; Alakus H
Anticancer Res; 2014 Jul; 34(7):3313-20. PubMed ID: 24982335
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression.
Jourdan F; Sebbagh N; Comperat E; Mourra N; Flahault A; Olschwang S; Duval A; Hamelin R; Flejou JF
Virchows Arch; 2003 Aug; 443(2):115-21. PubMed ID: 12802583
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach.
Takahashi R; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Oncology; 2003; 64(3):266-74. PubMed ID: 12697968
[TBL] [Abstract][Full Text] [Related]
11. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Maehara Y; Kabashima A; Koga T; Tokunaga E; Takeuchi H; Kakeji Y; Sugimachi K
Surgery; 2000 Sep; 128(3):408-16. PubMed ID: 10965312
[TBL] [Abstract][Full Text] [Related]
12. Improved technique for manually constructing tissue microarrays for large-core arrays.
Tsao SC; Wu CC; Wen CH; Chai CY; Chen YT
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):85-9. PubMed ID: 22595943
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor as an age-dependent prognostic factor in gastric cancer patients.
Minato E; Miki C; Tanaka K; Kobayashi M; Mohri Y; Tonouchi H; Kuribayashi K; Kusunoki M
Am J Surg; 2002 Nov; 184(5):460-4. PubMed ID: 12433614
[TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.
Tanigawa N; Amaya H; Matsumura M; Shimomatsuya T
J Clin Oncol; 1997 Feb; 15(2):826-32. PubMed ID: 9053510
[TBL] [Abstract][Full Text] [Related]
15. Distribution of vascular endothelial growth factor (VEGF) in prostate disease.
Walsh K; Sriprasad S; Hopster D; Codd J; Mulvin D
Prostate Cancer Prostatic Dis; 2002; 5(2):119-22. PubMed ID: 12497000
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?
Anagnostou VK; Lowery FJ; Syrigos KN; Cagle PT; Rimm DL
Arch Pathol Lab Med; 2010 Apr; 134(4):613-9. PubMed ID: 20367312
[TBL] [Abstract][Full Text] [Related]
17. Highly aggressive behavior and poor prognosis of small cell carcinoma in the stomach: flow cytometric and immunohistochemical analysis.
Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Tsuji M; Miwa A
Oncol Rep; 1999; 6(4):767-72. PubMed ID: 10373653
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.
Bauer AJ; Terrell R; Doniparthi NK; Patel A; Tuttle RM; Saji M; Ringel MD; Francis GL
Thyroid; 2002 Nov; 12(11):953-61. PubMed ID: 12490072
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
Fernebro E; Dictor M; Bendahl PO; Fernö M; Nilbert M
Arch Pathol Lab Med; 2002 Jun; 126(6):702-5. PubMed ID: 12033959
[TBL] [Abstract][Full Text] [Related]
20. Validation of tissue microarray technology in endometrioid cancer of the endometrium.
Fons G; Hasibuan SM; van der Velden J; ten Kate FJ
J Clin Pathol; 2007 May; 60(5):500-3. PubMed ID: 16822874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
